UPM Raflatac introduces new labeling solutions for medical device and healthcare applications in CPhI

UPM Raflatac will be present at the CPhl Innopack exhibition on 24-26 October 2017 in Frankfurt, Germany. Visitors will have the opportunity to discuss market developments and the latest solutions with UPM Raflatac’s pharmaceutical labeling experts in Hall 4.2, Stand 42J50.

UPM Raflatac will launch a brand new product range for medical device and healthcare industry. New RPMD is a multi-faceted adhesive that is ideal for labeling medical devices. Selection of different face materials with new RPMD adhesive are specially designed for different medical device sub-segments such as sterilization wraps and bags, infusion bags and bottles, drug-device combinations like pens, auto-injectors and inhalers and blood donation labeling. RPMD adhesive combines excellent adhesion with a tight mandrel hold on glass and plastic and is sterilization resistant and migration safe.

“In April 2017 the EU Commission formally adopted two new regulations on medical devices and in vitro diagnostic medical devices. One of the main regulatory updates is the implementation of a Unique Device Identification system (UDI) that provides a globally harmonized and consistent approach for the marking and identification of medical devices”, comments Markku Pietarinen, Manager, Business Segments & Pharma, Specials EMEIA. “A UDI is a code printed on a label affixed to a device or its packaging, or even directly on the device itself, in both plain text and machine-readable format. All medical devices available in the EU must comply with the new regulations by April 2020, with the deadline for in vitro diagnostic devices falling two years later, in 2022.”

Among UPM Raflatac’s most recent innovations is also a range of pharmaceutical labeling materials which support compliance with the Falsified Medicines Directive (2011/62/EU) regarding packaging for prescription drugs and high-risk, over-the-counter medicines. An estimated 30 billion such packs issued annually are affected in the EU. The deadline for compliance is February 2019 in the majority of EU member states.

The RP62 EU adhesive supplied with these tamper-verification products creates cardboard tear on typically used cardboard cartons carrying a water-based varnish. Our paper-based and filmic label faces all pair with RP62 EU adhesive are supporting legislative requirements for individually authenticated, tamper-evident packs, protecting the supply chain from counterfeits.
http://www.upm.com/About-us/Newsroom/Releases/Pages/UPM-Raflatac-introduces-new-labeling-solutions-for-medical-device-and-healthcare-001-Tue-17-Oct-2017-11-03.aspx

Related Posts

BillerudKorsnäs joins fight against ocean litter, announces U.S. events

BillerudKorsnäs is encouraging action against ocean litter in a series of just-announced U.S. events, in theme with this year's World Oceans Day. The Swedish company has outlined an ambitious mission to challenge conventional packaging and bring more sustainable practices to the industry. "Between the growing chorus from consumers to address single-use packaging waste to reports from ocean researchers on declining ocean health, the problem of ocean litter has reached critical awareness," said Peter Malmqvist, BillerudKorsnäs Marketing Director, Americas. "What we need now is collaboration for sustainable development." BillerudKorsnäs will bring together business leaders and consumers in a series of U.S. events as part of its mission to challenge conventional packaging, as well as its partnership with Tara Expeditions Foundation, a floating research institute studying the ecological crisis in the oceans on a globe-traversing schooner. Click Read More below for additional information.

WestRock to Build New Corrugated Packaging Plant in Brazil

“WestRock’s corrugated packaging business in Brazil continues to perform well, with strong relationships with customers in attractive growth markets,” said Steve Voorhees, chief executive officer, WestRock. “Our new corrugated packaging plant will enable our exceptional team in Brazil to serve these customers even better in the future, with a state-of-the-art manufacturing facility that will provide new capabilites and efficiences for our customers, and to further integrate the containerboard that we manufacture in Brazil.” The new facility will be located in Porto Feliz and will serve all industry segments and markets both in the highly developed Sao Paulo region, as well other growing areas in Brazil’s southeast region. Construction is expected to begin later this year and be completed in mid-2019.

Metsä Board’s comparable operating result in January–December 2022 was EUR 521 million

January–December 2022 (compared to 1–12/2021): Sales were EUR 2,479.6 million (2,084.1). The comparable operating result was EUR 520.7 million 386.6), or 21.0% of sales (18.6). Operating result was EUR 531.5 million (375.9). Comparable earnings per share were EUR 1.13 (0.85), and earnings per share were EUR 1.15 (0.82). Comparable return on capital employed was 20.9 % (18.7). Net cash flow from operations was EUR 232.0 million (329.6). October–December 2022 (compared to 10–12/2021): Sales were EUR 599.8 million (518.5). The comparable operating result was EUR 100.8 million (91.3), or 16.8% (17.6) of sales. Operating result was EUR 94.7 million (90.8). Comparable earnings per share were EUR 0.23 (0.20), and earnings per share were EUR 0.21 (0.19). Comparable return on capital employed was 15.5% (16.1). Net cash flow from operations was EUR 70.2 million (119.7).
Back To Top
×Close search
Search